"Health & Medical News"

Washington — A new Medicare coverage policy on drug treatment for anemic cancer patients is hurting care, according to a survey of doctors released last month.

Ninety-one percent of oncologists and hematologists reported adverse patient events in the 12 weeks after the July 30 implementation of the national coverage determination on erythropoiesis-stimulating agents. The poll was sponsored by U.S. Oncology, which funds, develops, and helps manage 443 cancer centers in 39 states. It surveyed 307 physicians from Nov. 26, 2007, to Dec. 11, 2007. The organization limited the number of affiliated physicians involved in the poll to 20% of all respondents.

Read the rest of this entry »

Popularity: unranked [?]

Washington — Two national medical societies issued guidelines on Oct. 22 for treating chemotherapy-related anemia with erythropoiesis-stimulating agents to pressure Medicare into expanding its coverage. Their move follows a decision by Aetna to cover a more relaxed protocol for the medications than the government adopted.

Read the rest of this entry »

Popularity: unranked [?]

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

Prescribing exercise, with referrals and instruction. Emphasizing ways that people with arthritis can modify exercise to accommodate physical

New Exercise Class For People With Arthritis Scheduled At Fort Boise
Read the rest of this entry »

Popularity: unranked [?]